Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
Operating Expenses | 2,290 | 218 | 2,330 | 1,883 | 0 |
Operating Income | -2,290 | -218 | -2,330 | -1,883 | N/A |
Interest Expense | 3 | 3 | 0 | 0 | 0 |
Other Income | 4,533 | -2 | 101 | 143 | 0 |
Pre-tax Income | 2,240 | -223 | -2,229 | -1,740 | 0 |
Net Income Continuous | 2,240 | -223 | -2,229 | -1,740 | N/A |
Net Income | $2,240 | $-223 | $-2,229 | $-1,740 | $N/A |
EPS Basic Total Ops | 120.00 | 0.00 | -80.00 | -80.00 | N/A |
EPS Basic Continuous Ops | 110.99 | -6.08 | -80.12 | -70.35 | N/A |
EPS Diluted Total Ops | 120.00 | 0.00 | -80.00 | -80.00 | N/A |
EPS Diluted Continuous Ops | 110.99 | -6.08 | -80.12 | -70.35 | N/A |
EBITDA(a) | $-2,284 | $-218 | $-2,330 | $-1,883 | $N/A |